You May Also Like

horoscope of the day setting intentions

Intention-setters, there’s some serious astrological mojo supporting you right now

Vital Scout by VivaLNK

Everyone is freaking out about stress—and this new wearable patch promises to help you track yours

Does acupuncture work?

Acupuncture is officially going mainstream—but will it work for you?

Feng shui bedroom tips to improve your love life

9 bedroom decor tips to better your relationship, according to a feng shui expert

hypnotism

I went to a hypnotist to get over my breakup—here’s what happened

Vaginal dryness treatments

It’s as dry as the desert down there—what the heck is going on?

The medical world is taking inflammation (even more) seriously thanks to a new study


Thumbnail for The medical world is taking inflammation (even more) seriously thanks to a new study
Pin It
Photo: Stocksy/Alita Ong

There’s a reason why inflammation is one of the biggest buzzwords in the wellness space: Experts say keeping it at bay via anti-inflammatory foods, hyperbaric oxygen chambers, and an occasional healthy cocktail (because #balance) helps with everything from skin conditions and allergies to preventing chronic diseases and painful periods. And now the medical world is corroborating some of the claims.

Being dubbed as a “major milestone” study in the health industry, researchers found that the inflammation-fighting drug canakinumab—marketed under the name Ilaris—reduces the risk of heart attacks, strokes, and possibly lung cancer in those who have already had one heart attack (and have a strong chance of having another).

“This is the first definitive clinical trial support for the concept that inflammation-targeted therapy reduces the risk of cardiovascular disease.”

According to the New York Times, researchers have suspected for quite some time that inflammation plays a role in cardiovascular disease and cancer, but now they’re seeing the proof they need in order to believe it. In the study, 10,061 participants from 39 different countries were randomly chosen to either receive a placebo or an injection of canakinumab every few months for about four years. Those who received the drug were 15 percent less likely to have a heart attack or a stoke or die of cardiovascular disease than those on the placebo.

“[This is] the first definitive clinical trial support for the concept that inflammation-targeted therapy reduces the risk of cardiovascular disease. I think that’s extraordinarily important,” Daniel J. Rader, MD, an expert in preventive cardiology at the University of Pennsylvania, told The New York Times.

While the term “inflammation” has long been a buzzword in holistic nutrition circles, this study could make it a topic of conversation at your annual visit with your general practitioner. (So, for your next appointment: Here are some Instagram-ready anti-inflammatory drink recipes you can share with him or her.)

Beat inflammation like Jessica Alba with these small tweaks to your diet. And if you really want to live an anti-inflammatory lifestyle, here are 16 more ways to do it.

Loading More Posts...

You May Also Like

Everything to know about monstera plant care

Monstera hysteria has broken out on Pinterest, but what on earth is the thing?

The easy-to-miss laundry mistake that's destroying your favorite clothes

Zippers are a likely culprit of your favorite clothes getting ruined in the laundry

Vital Scout by VivaLNK

Everyone is freaking out about stress—and this new wearable patch promises to help you track yours

hypnotism

I went to a hypnotist to get over my breakup—here’s what happened

Dating hacks from real women

8 dating hacks from real women on the front lines of singledom

Supplements for mental health

5 supplements that can help boost your mental health, according to an MD